Skip to main content

Articles

Multiple Myeloma, Oncology
Consistent Benefit Over Time in Elotuzumab Studies
Read More
Multiple Myeloma, Oncology
Daratumumab Improves Overall Survival in Multiple Myeloma
Read More
Checkpoint Inhibitors in Lymphoma: A New Universe
Read More
CAR T-Cell Therapy Highly Active in Various Lymphomas
Read More
Leukemia, Oncology
Nilotinib Yields Better Rates of Molecular Response Than Imatinib in Frontline Setting
Read More
Leukemia, Oncology
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Read More
Leukemia, Oncology
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Read More
Leukemia, Oncology
Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia
Read More
FDA Approvals
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Read More
FDA Approvals
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Read More
Page 118 of 244
Results 1171 - 1180 of 2439